These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35734430)

  • 41. White box radial basis function classifiers with component selection for clinical prediction models.
    Van Belle V; Lisboa P
    Artif Intell Med; 2014 Jan; 60(1):53-64. PubMed ID: 24262978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
    Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
    Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel approach for data integration and disease subtyping.
    Nguyen T; Tagett R; Diaz D; Draghici S
    Genome Res; 2017 Dec; 27(12):2025-2039. PubMed ID: 29066617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.
    Nalls MA; Blauwendraat C; Vallerga CL; Heilbron K; Bandres-Ciga S; Chang D; Tan M; Kia DA; Noyce AJ; Xue A; Bras J; Young E; von Coelln R; Simón-Sánchez J; Schulte C; Sharma M; Krohn L; Pihlstrøm L; Siitonen A; Iwaki H; Leonard H; Faghri F; Gibbs JR; Hernandez DG; Scholz SW; Botia JA; Martinez M; Corvol JC; Lesage S; Jankovic J; Shulman LM; Sutherland M; Tienari P; Majamaa K; Toft M; Andreassen OA; Bangale T; Brice A; Yang J; Gan-Or Z; Gasser T; Heutink P; Shulman JM; Wood NW; Hinds DA; Hardy JA; Morris HR; Gratten J; Visscher PM; Graham RR; Singleton AB; ; ;
    Lancet Neurol; 2019 Dec; 18(12):1091-1102. PubMed ID: 31701892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort.
    Weyerer V; Stoehr R; Bertz S; Lange F; Geppert CI; Wach S; Taubert H; Sikic D; Wullich B; Hartmann A; Eckstein M
    World J Urol; 2021 Nov; 39(11):4011-4019. PubMed ID: 34259899
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design considerations for genetic linkage and association studies.
    Nsengimana J; Bishop DT
    Methods Mol Biol; 2012; 850():237-62. PubMed ID: 22307702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A unified graph model based on molecular data binning for disease subtyping.
    Hassan Zada MS; Yuan B; Khan WA; Anjum A; Reiff-Marganiec S; Saleem R
    J Biomed Inform; 2022 Oct; 134():104187. PubMed ID: 36055637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular Subtyping of Cancer Based on Distinguishing Co-Expression Modules and Machine Learning.
    Sun P; Wu Y; Yin C; Jiang H; Xu Y; Sun H
    Front Genet; 2022; 13():866005. PubMed ID: 35586568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cluster Analysis of Categorical Variables of Parkinson's Disease Patients.
    Hendricks R; Khasawneh M
    Brain Sci; 2021 Sep; 11(10):. PubMed ID: 34679355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive subtyping of Parkinson's disease patients with similarity fusion: a case study with BioFIND data.
    Brendel M; Su C; Hou Y; Henchcliffe C; Wang F
    NPJ Parkinsons Dis; 2021 Sep; 7(1):83. PubMed ID: 34535682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening and clustering of sparse regressions with finite non-Gaussian mixtures.
    Zhang J
    Biometrics; 2017 Jun; 73(2):540-550. PubMed ID: 27599032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of associations between genotypes and longitudinal phenotypes via temporally-constrained group sparse canonical correlation analysis.
    Hao X; Li C; Yan J; Yao X; Risacher SL; Saykin AJ; Shen L; Zhang D;
    Bioinformatics; 2017 Jul; 33(14):i341-i349. PubMed ID: 28881979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Data-Driven Subtyping of Parkinson's Disease Using Longitudinal Clinical Records: A Cohort Study.
    Zhang X; Chou J; Liang J; Xiao C; Zhao Y; Sarva H; Henchcliffe C; Wang F
    Sci Rep; 2019 Jan; 9(1):797. PubMed ID: 30692568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Precision medicine for Parkinson's disease: The subtyping challenge.
    Frasier M; Fiske BK; Sherer TB
    Front Aging Neurosci; 2022; 14():1064057. PubMed ID: 36533178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subtyping of early-onset Parkinson's disease using cluster analysis: A large cohort study.
    Zhou Z; Zhou X; Xiang Y; Zhao Y; Pan H; Wu J; Xu Q; Chen Y; Sun Q; Wu X; Zhu J; Wu X; Li J; Yan X; Guo J; Tang B; Lei L; Liu Z
    Front Aging Neurosci; 2022; 14():1040293. PubMed ID: 36437996
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.